While our ability to collect large amounts of experimental data in a timely and cost-effective manner represented, until recently, a top priority, a different challenge is currently taking shape. Now ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ('INBS' or the 'Company'), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided an update on its FDA ...

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the commercial launch of the PhysioMimix™ ...

The drug-testing system screens fingerprint sweat for recent use of drugs, returning results in under ten minutes, the New York company said. Intelligent Bio said it is currently evaluating the FDA's ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capital has enabled ...

Peptide mapping analysis of protein digestions is a critical component of biopharmaceutical development and manufacturing. The demanding method conditions required to perform these complex separations ...

Intelligent Bio Solutions Inc. (INBS) has submitted a 510(k) premarket notification to the FDA for its Intelligent Fingerprinting Drug Screening System, a rapid and non-invasive drug testing method ...

CN Bio, a leading developer of single and multi organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the publication of ...